{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-038647","form_type":"8-K","ticker":"DRMA","cik":"0001853816","company_name":"Dermata Therapeutics, Inc.","filed_at":"2026-08-17T12:30:36+00:00","discovered_at":"2026-08-17T12:35:00.454297+00:00","generated_at":"2026-08-17T12:35:34.309988+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Dermata raises $3.4M in private placement of shares and warrants","bullets":["Gross proceeds ~$3.4M; net ~$3.2M after expenses; closing expected Aug 18, 2026.","Issued 2,293,608 shares (or pre-funded warrants) plus series E and F warrants for 2,293,608 shares each at $1.46.","Insiders (CEO, CFO, management) bought ~4.9M shares/warrants for ~$2.4M at $1.47 per unit.","Warrants exercisable at $1.46; series E expire 5 years, series F expire 24 months from stockholder approval; potential $6.7M if exercised.","Proceeds for general corporate purposes, including OTC acne kit launch and R&D."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-038647","json":"https://secwatch.observer/filing/0001493152-26-038647.json","markdown":"https://secwatch.observer/filing/0001493152-26-038647.md","text":"https://secwatch.observer/filing/0001493152-26-038647.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1853816/000149315226038647/0001493152-26-038647-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1853816/000149315226038647/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-17T12:35:34.309988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}